je bezig met onder andere e-mailmarketing, social media, website-optimalisatie, copywriting, PR en de organisatie van... marketingmateriaal (brochures, advertenties, social media, enz.)in; Je coördineert PR-activiteiten in samenwerking met een extern bureau...
. Je werk is zichtbaar en impactvol, van folders en campagnes tot online media. Jij denkt actief mee, neemt verantwoordelijkheid... én de deadlines. Content creëren en beheren voor social media, mailings, advertenties en de website. Originele acties, campagnes...
Faites la différence pour les patients Nous recherchons un.e Production Leader talentueux.se et motivé.e pour rejoindre notre Belgium Biomanufacturing Operations Center à Braine-L’Alleud, Belgique. Ici, vous pouvez réellement enrichir ...
do: Bij Jan De Nul bedenken, maken en verspreiden we onze communicatie zelf. Campagnes, video's, events, beurzen, sociale media... takenpakket: Je vertaalt de corporate strategie naar een duidelijk extern beeld en je voert hiervoor acties uit op sociale media...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »